--:--:--

Lotus Eye Hospital and Institute Limited

Web: lotuseye.org NSE: LOTUSEYE BSE: 532998 SECTOR: Healthcare - Healthcare Services | Add Note | View Notes

110 0(0%)

Volume

12k as on 23, Jun

Open

0

High

0

Low

0

Close

110

VWAP

125

52 Week High

147

52 Week Low

98

Viand Research Rating
Quality Score

43/100

Growth Score

64/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

229

No. of Shares

2.08

P/E

103.48

P/B

2.45

Face Value

10

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

2.37

ROCE

-

Profit Growth

-

Listing Date

11-Jul-08

Rank/Sector Rank

#2509/#160

Promoter Holding

40.14%

FII Holding

-

DII Holding

0.02%

Price Chart
Price Performance
1 Week11%
1 Month14%
3 Months19%
6 Months14%
1 Year14%
YTD14%
Moving Average
5 Day SMA130
10 Day SMA132
20 Day SMA122
30 Day SMA118
50 Day SMA117
61 Day SMA115
80 Day SMA0
200 Day SMA0
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 3136129134135
Resistance 2134128132133
Resistance 1131128130129
Pivot Point128127128127
Support 1125127126123
Support 2123126125122
Support 3119126123118
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqNP Qtr Rs.Cr.
1SUNPHARMA4,18,69817450%5%4%4%3755.50.0711509
2DIVISLAB2,43,96691902%0%45%38%6955.502568
3TORNTPHARM1,73,20845542%5%10%28%7255.51.792138
4ZYDUSLIFE1,11,45111170%1%20%12%2055.50.313560
5APOLLOHOSP1,09,27676002%9%4%1%5855.50.92003
6LAURUSLABS1,08,73820121%8%83%124%055.50.48890
7CIPLA1,06,15413142%2%8%19%2255.50.023862
8DRREDDY1,03,87312443%8%1%4%2055.50.24158
9MANKIND94,40122864%1%8%7%4955.50.391938
10AUROPHARMA90,84115792%1%20%52%055.50.192415
Load More
Shareholding Pattern (%)
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Promoters(0.01) 40.14%(-0.51) 40.14%(0.01) 40.66%(0.21) 40.63%(0.21) 40.39%(0.11) 40.22%(0.11) 40.14%(-0.21) 40.03%(-1.21) 40.24%(-15.21) 41.40%(-1.01) 56.58%(-0.91) 57.58%(0.31) 58.44%(0.01) 58.17%(0.31) 58.14%(0.11) 57.88%(0.01) 57.74%(0.01) 57.74%(0.01) 57.74%(0.01) 57.74%
FIIs(0.01) 0.00%(0.01) 0.00%(0.01) 0.01%(0.01) 0.00%(0.01) 0.01%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%
DIIs(0.01) 0.02%(0.01) 0.02%(0.01) 0.02%(0.01) 0.02%(0.01) 0.02%(0.01) 0.04%(0.01) 0.04%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%
Public59.85%59.85%59.31%59.33%59.57%59.73%59.82%59.97%59.76%58.60%43.42%42.43%41.56%41.83%41.86%42.12%42.26%42.26%42.26%42.26%
No. of Shareholders9,6279,93910,24010,77711,12111,50811,73412,51411,75912,5028,3147,6607,4257,3457,4167,4167,0316,8306,2266,175
Quarterly Results
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Sales17.0613.6113.5513.0413.5211.5112.2512.9112.8910.8812.0312.7312.5711.1712.1411.8611.8710.5711.6110.81
Sales Growth % (YoY)26.2%18.2%10.6%1%4.9%5.8%1.8%1.4%2.6%-2.6%-0.9%7.3%5.9%5.7%4.6%9.7%100.5%-17.6%50.8%
Sales Growth % (QoQ)25.3%0.4%3.9%-3.6%17.5%-6%-5.1%0.2%18.5%-9.6%-5.5%1.3%12.5%-8%2.4%-0.1%12.3%-9%7.4%-
Expenses14.1113.1312.8912.2712.0411.6811.4611.7611.2310.1210.4510.9210.189.7810.0310.19.559.339.268.72
Operating Profit2.950.480.660.771.48-0.170.791.151.660.761.581.812.391.392.111.762.321.242.352.09
OPM %17.293.534.875.910.95-1.486.458.9112.886.9913.1314.2219.0112.4417.3814.8419.5511.7320.2419.33
Other Income0.210.470.240.270.190.520.220.270.310.40.340.280.290.360.320.230.240.280.220.21
Interest0.510.330.290.120.120.090.130.080.060.030.040.010.020.020.020.030.030.030.040.04
Depreciation1.641.10.980.850.82-0.581.311.231.061.120.980.890.730.780.770.750.680.750.630.6
Profit before tax1.01-0.48-0.370.070.730.84-0.430.110.850.010.91.191.930.951.641.211.850.741.91.66
Tax %39.6-33.33-29.73-71.4324.6670.24-44.199.0928.24-20026.6728.5727.9831.5829.8824.7926.4927.0326.8424.7
Net Profit 0.61-0.32-0.260.120.540.25-0.240.10.620.020.660.851.380.651.160.91.370.541.391.25
Net Profit Growth % (QoQ)290.6%-23.1%-316.7%-77.8%116%204.2%-340%-83.9%3000%-97%-22.4%-38.4%112.3%-44%28.9%-34.3%153.7%-61.2%11.2%-
Net Profit Growth % (YoY)13%-228%-8.3%20%-12.9%1150%-136.4%-88.2%-55.1%-96.9%-43.1%-5.6%0.7%20.4%-16.5%-28%----
TTM Net Profit0.150.080.650.670.650.730.51.42.152.913.544.044.094.083.974.24.553.182.640
EPS in Rs0.29-0.15-0.130.060.260.12-0.120.050.30.010.320.410.660.310.560.430.660.260.670.6
Profit and Loss
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
Sales53.749.5548.247.0338.932.3540.5538.4338.0233.9631.1329.928.6929.11
Sales Growth %8.4%2.8%2.5%20.9%20.2%-20.2%5.5%1.1%12%9.1%4.1%4.2%-1.4%11%
Expenses50.1545.9941.5739.3532.9828.7336.5735.2133.6830.6327.1427.7225.425.51
Operating Profit3.553.566.637.685.923.623.983.224.343.333.992.183.293.6
OPM %6.617.1813.7616.3315.2211.199.828.3811.429.8112.827.2911.4712.37
Other Income1.181.311.311.150.880.840.210.680.910.680.580.460.390.64
Interest1.030.480.20.20.210.140.240.210.180.150.160.10.040.05
Depreciation3.753.013.732.982.52.332.53.063.373.444.444.763.543.73
Profit before tax-0.051.384.015.654.091.991.450.631.70.42-0.03-2.220.10.46
Tax %-28046.3827.4327.7927.1421.1126.9-12.7-2.35-7.14-400-10.81608.7
Net Profit 0.080.742.914.082.981.571.060.711.750.440.1-1.980.040.42
Net Profit Growth %-89.2%-74.6%-28.7%36.9%89.8%48.1%49.3%-59.4%297.7%340%105.1%-5050%-90.5%-
EPS in Rs0.040.361.41.961.430.750.510.340.840.210.05-0.950.020.2
Dividend Payout %00025.4934.966.240059.43236.360000
Cash Flows
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
Cash from Operating Activity3.022.75.684.394.412.734.974.25.782.973.382.374.413.71
Cash from Investing Activity-14.39-6.13-4.63-2.19-3.940.49-0.68-4.01-3.86-1.06-0.85-4.65-5.05-1.2
Cash from Financing Activity9.03-1.6-3.4-1.71-1.58-0.320.13-1.41-1.51-0.25-0.581.87-0.77-0.16
Net Cash Flow-2.34-5.03-2.350.49-1.12.94.42-1.220.411.661.96-0.4-1.412.35
Balance Sheet
Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013
Equity Capital20.820.820.820.820.820.820.820.820.820.820.820.820.820.820.820.8
Reserves39.3439.8239.239.3138.6136.7833.8131.930.4629.3229.8429.2628.6928.5930.5730.53
Borrowings15.834.83.4301.110.671.240.40.320.220.290.480.660.830.180.26
Other Liabilities6.636.096.149.966.114.935.756.126.536.187.284.44.686.27.015.31
Total Liabilities82.671.5169.5770.0766.6363.1861.659.2258.1156.5258.2154.9454.8356.4258.5656.9
Fixed Assets65.8155.1754.0752.8448.6544.1844.0740.5442.6744.1442.5241.3243.5747.0446.9445.31
CWIP0.090.06000.0800000.290.290.650.420.270.360.18
Investments0000000000000000
Other Assets16.716.2815.517.2317.91917.5318.6815.4412.0915.412.9710.849.1111.2611.41
Total Assets82.671.5169.5770.0766.6363.1861.659.2258.1156.5258.2154.9454.8356.4258.5656.9
Delivery

Delivery Data: LOTUSEYE

#Date
105
14%
120
Value (Cr)Q/T
90
Del
72
Del
0
121-Oct110
0
38860
219-Oct110
1
166901
316-Oct114
0
31730
415-Oct109
1
69831
514-Oct112
0
96820
613-Oct111
1
152731
712-Oct107
0
32900
89-Oct114
0
44860
98-Oct114
0
25630
107-Oct115
0
18940
116-Oct115
0
112870
125-Oct116
0
32730
131-Oct116
0
46880
1430-Sep116
0
13790
1529-Sep113
0
51800
1628-Sep115
0
40870
1725-Sep115
0
27800
1824-Sep113
0
38700
1923-Sep115
0
36780
2022-Sep115
0
99910
2121-Sep115
0
36760
2218-Sep115
0
100930
2317-Sep113
0
22920
2416-Sep115
0
47760
2515-Sep111
0
22770
2611-Sep114
0
23790
2710-Sep112
0
47650
289-Sep111
0
29780
298-Sep111
0
107920
307-Sep109
0
15690
314-Sep109
0
69800
323-Sep109
0
16720
332-Sep108
0
58930
341-Sep109
0
38800
3531-Aug109
0
90810
3628-Aug111
0
70710
3727-Aug113
0
28660
3826-Aug112
0
53500
3925-Aug114
0
73800
4024-Aug116
0
38880
4121-Aug116
0
56490
4220-Aug117
0
104840
4319-Aug116
0
74840
4418-Aug116
0
59820
4517-Aug116
0
20530
4614-Aug115
0
45660
4713-Aug117
0
39780
4812-Aug118
0
39830
Daily Market Cap
DateTotal Market CapChangeChg %
21-Oct229c46L0.20
19-Oct229c10c4.34
17-Oct239c00
16-Oct239c10c4.39
15-Oct229c33L0.15
14-Oct229c1c0.46
13-Oct228c2c0.95
12-Oct226c13c5.43
09-Oct239c2c0.61
08-Oct237c8c3.31
05-Oct245c4c1.73
01-Oct241c3c1.03
29-Sep239c1c0.46
28-Sep238c00
25-Sep238c2c0.87
24-Sep236c4c1.55
22-Sep239c5c1.92
17-Sep235c73L0.31
10-Sep234c4c1.71
07-Sep230c2c0.67
04-Sep228c00
Stock Checklist
Price is above from 52 week high low average: 26%
Stock is trading above all short term SMAs: NO
Stock is trading above all long term SMAs: YES
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: NO
Promoters are buying the stock: NO
Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
For research & education only — not investment advice. Not a SEBI-registered Investment Adviser or Research Analyst. Data may be delayed or inaccurate. Investments in securities markets are subject to market risks.
0